COVID-19 Pneumonia in Children: From Etiology to Management

COVID-19 is less serious in children than in adults. However, respiratory management dominates the clinical picture of hospitalized COVID-19 even in children. In some case series, deterioration of the clinical picture wherein dyspnea, cyanosis, and the onset of acute respiratory distress syndrome (A...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pediatrics Vol. 8; p. 616622
Main Authors Parisi, Giuseppe Fabio, Indolfi, Cristiana, Decimo, Fabio, Leonardi, Salvatore, Miraglia Del Giudice, Michele
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 14.12.2020
Subjects
children
COVID-19
Pediatrics
pneumonia
SARS-CoV2
treatment
COVID-19
SARS-CoV2
treatment
pneumonia
children
Online AccessGet full text

Cover

More Information
Summary:COVID-19 is less serious in children than in adults. However, respiratory management dominates the clinical picture of hospitalized COVID-19 even in children. In some case series, deterioration of the clinical picture wherein dyspnea, cyanosis, and the onset of acute respiratory distress syndrome (ARDS) emerged ~8-10 days after the onset of SARS-CoV-2 infection, which could rapidly progress to multiple organ failure and death. This review aimed to evaluate the characteristics of COVID-19 pneumonia in pediatric populations, beginning from its etiology and pathological mechanisms and closing with its clinical management.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Pediatric Pulmonology, a section of the journal Frontiers in Pediatrics
Edited by: Hong-Ren Yu, Chang Gung Memorial Hospital, Taiwan
Reviewed by: Chung-Ming Chen, Taipei Medical University, Taiwan; HaiLun Sun, Chung Shan Medical University Hospital, Taiwan
ISSN:2296-2360
2296-2360
DOI:10.3389/fped.2020.616622